PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Zinc Chloride→

Zinc Chloride PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7646-85-7
Molecular formula
Cl2Zn
Molecular weight
136.29 g/mol
Drug class
Essential trace elementzinc replacement and supplementation
Mechanism of action
Zinc is an essential divalent cation and cofactor for numerous enzymes and transcription factors involved in nucleic-acid synthesis, protein synthesis, immune function, cell division, wound healing and epithelial integrity. Zinc salts dissociate to provide zinc; counter-ions affect elemental zinc content and formulation, not the core biological target.
Indications / reported uses
  • Prevention and treatment of zinc deficiency
  • Nutritional supplementation when intake or absorption is inadequate; route, elemental dose and product-authorised claims depend on formulation and jurisdiction

Sources: NIH Office of Dietary Supplements — Zinc fact sheet · WHO — Zinc supplementation in management of diarrhoea

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Zinc Chloride PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Zinc Chloride Permitted Daily Exposure (PDE) report (the Zinc Chloride PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Zinc Chloride Occupational Exposure Limit (OEL) report (the Zinc Chloride OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.